Personal information

No personal information available

Activities

Collapse all

Works (1)

Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial

Journal of Gynecologic Oncology
2021 | Journal article
DOI: 10.3802/jgo.2021.32.e9
Contributors: Takashi Motohashi; Akira Yabuno; Hiroshi Michimae; Tetsuro Ohishi; Miwa Nonaka; Masashi Takano; Shin Nishio; Hiroyuki Fujiwara; Keiichi Fujiwara; Eiji Kondo et al.
Source: check_circle
Crossref
How many people are using ORCID?